now browsing by category
Prostate cancer is the most common form of cancer found in men and can be spotted in those aged over 40 using the simple to administer Prostate Specific Antigen test. The Cancer Treatment Centers of America has partnered with the National Football League Alumni association and LabCorp to try and raise awareness of the medical condition alongside offering a special discount for prostate cancer screening; the first 2,000 men over 40 applying for the Prostate Specific Antigen test will not be charged and those who follow will receive screening for the discounted cost of just $25.
The Cancer Treatment Centers of America has been looking for different ways of raising awareness of prostate cancer among men above the age of 40 and is now working with former head coaches from the NFL. Prostate cancer awareness month will be the time when public service announcements featuring some of the most popular former head coaches of recent years will air to assist in raising awareness about this commonly seen form of cancer. Those who have a family history of prostate cancer and from specific racial groups have an increased risk of being diagnosed with this form of cancer.
Finding success in the healthcare industry has been completed in just three decades by the Cancer Treatment Centers of America which has seen four of its five facilities awarded five-star ratings from U.S. Centers for Medicaid and Medicare Services. A number of other leading healthcare service providers have also praised the Cancer Treatment Centers of America for their excellent service including the Association of Community Cancer Centers.
The success seen in the U.S. by the Cancer Treatment Centers of America has seen the cancer treatment provider develop its presence across much of the Middle East and portions of South and Central America.
Visit More : www.myctca.com
Dr Jennifer Walden is a plastic surgeon based in Austin, Texas who is certified by the American Board of Aesthetic plastic surgery. She graduated from the University of Texas with an undergraduate in Biology and later applied to medical at the University of Texas Medical Branch where she was the salutatorian for her graduating class. Dr. Sherrell Aston led Dr. Jennifer at the Manhattan Eye, Ear and Throat hospital in obtaining her Fellowship in cosmetic surgery.
In December 2011 Dr Jennifer Walden moved back to Texas for her sons can be raised near the family, this was after working for seven and a half years in New York Upper East Side. She later opened up Jennifer L. Walden, MD, PLLC & Walden Cosmetic Surgery And Laser Center in Westlake Hills,Texas in May 2012. It is a laser center with advanced laser specialist, a team of aestheticians, cosmetic injectors and a fully accredited Office operating facility. She has specialized in face-lifts, nose jobs, breast augmentation,liposuction ,eyelid lifts, injecting botox and soft tissue fillers. She has presented on this topics nationally and internationally and learn more about Jennifer.
Dr. Jennifer Walden is as a Fellow of the American College of Surgeons and is the Vice Commissioner of the American Society for aesthetic Plastic Surgeons Board of directors. She is also the spokesperson for both American Society of Plastic surgeons as well as the American Society for aesthetic Plastic Surgeons. She has received numerous awards and has various society memberships.
Dr Walden was recognized by America Way as the best plastic surgeon in America. In her practice she uses advanced technologies and is known for using 3-D imaging technology which visualizes a patients look before surgery, radio frequency systems for vaginal tightening and the Thermiva. She has also developed instruments used for breast surgery and is a consultant for aesthetic companies and more information click here.
Amicus Therapeutic is a biopharmaceutical company. This organization was founded in 2002 and it works to combat orphan and rare diseases. Amicus was founded by different venture capital firms who combined their resources. These firms include Radius Ventures, Canaan Partners and New Enterprise Associates. The company is led by three key people which include CEO John Crowley, COO Bradley Campbell and the company’s Chief Financial Officer, Willian Baird.
Amicus Therapeutics is a leading research and treatment facility in the fight against rare diseases. An orphan disease is a condition that is experienced by 200,000 people or fewer within a large population of people. A rare disease is defined by its ability to affect a small percentage of a population. Most rare diseases are genetic and the same is also true for orphan diseases.
The founders of Amicus realize that rare diseases can still negatively impact various ethnic groups and populations from around the world. Diseases such as cystic fibrosis, Lou Gehrig’s disease, Hamburger disease and Tourette’s syndrome falls into the rare and orphan diseases categories. Other diseases such as gigantism and job syndrome are also treated by this medical organization.
Various pharmaceutical treatment options consist of the Chaperone-Advanced Replacement Therapy or CHART. This is a proven enzyme replacement therapy that the founders use to treat people. CHART is the company’s leading treatment drug. It is used for various patients with unique conditions. This company has been helping the medical community to find viable solutions with their efforts in eliminating specific diseases.
Amicus Therapeutics opened up another facility in San Diego, California in 2008. Their original location is in Cranbury, New Jersey. This organization has also acquired Callidus Biopharma and Scioderm. These acquisitions helped Amicus Therapeutics expand its research and treatment options to combat unusual diseases such as Pompe. Amicus Therapeutics brings in a revenue of $18 million per year and is growing in a positive direction.
Dr. Andrew Manganaro was born and raised in Brooklyn, New York. He attended college and graduated with honors after studying Philosophy and Biology. He went on to attend New York University School of Medicine, where he received his Doctorate. Dr. Manganaro did his residency at New York University/Bellevue Hospital Medical Center and UCLA School of Medicine, respectively. He spent the next 35 years as a surgeon, and once he retired he accepted the position of Chief Medical Officer at Life Line Screening. He got the idea for Life Line Screening by watching his patients come in with internal bleeding and injuries that were preventable if they had known about them before they became big problems. Dr. Mangarnaro believes in assessing your failures to see what you did wrong and learn from them, keep up with scientific research, so you know what is working and what isn’t working, and never stop looking for answers.
Life Line Screening
Life Line Screening is a privately owned company that was founded Florida in 1993. Life Line Screening expanded to the Midwest in 1996, and by 1999 they were found throughout the United States. This company has grown to employ over 1,000 staff members, all who are trained in preventative medicine. Life Line Screening advanced in 2007 to offer preventative care in the United Kingdom, and to Austraila in 2012. An initial Life Line Screening exam is done through either ultrasound, finger-stick blood screenings, and electrocardiograph screenings.
Ultrasound Screening. Electrocardiograph.Finger Stick Blood Screenings.
- Ultrasound Screening. An ultrasound screening is performed by putting a device that uses sound waves to show pictures of the inside of the body. This procedure helps predict carotid artery disease, peripheral arterial disease, osteoporosis risks, and aneurysms.
- Electrocardiograph. An Electrocardiograph screening is performed to help detect issues that may lead to a stroke or heart attack, like an irregular heartbeat.
- Finger Stick Blood Screenings. This procedure checks a patient’s blood for risk factors that can contribute to high cholesterol, heart disease, and diabetes.
Dr. Andrew Manganaro and Life Line Screening know the importance of catching things early before they become life threatening. This company will continue to educate patients on relevant risk factors and help them lead a healthier lifestyle.
To know more visit @ www.lifelinescreening.com/Who-We-Are/Careers
Autism Rocks is a traveling festival that puts on shows featuring some of the most renowned entertainers. It has hosted events in cities all over the world from Madrid to New Delhi, and all funds received from ticket purchases go towards research and cures for autism. Millionaire entrepreneur Sanjay Shah, the founder of Solo Capital is the man who started up Autism Rocks, and he did so because the disease is something he knows about. His young son Nikhil has had to work through the struggles of autism, but Sanjay hopes that this festival, recently hosted in his home city Dubai, will help others affected by the disease, and maybe one day help find a cure for it.
Sanjay Shah has always had an interest in health and medicine, and at one point he was going to be a doctor. But when medical school fell through, he decided to take up business and accounting instead. He became certified and was hired by several big banks like Morgan Stanley and Citibank, and he was very proficient at his job, but he still felt he was not reaching the goals of what he really wanted to do with his life.
Things took a turn for the worse for Shah when he lost his job in 2009 because of the financial crash. He was nearly broke, but he had a little money to get a small room in a corner outlet of a London building. It was there that he started up Solo Capital, an investment boutique company that managed clients funds and gave sound investment advice. He was able to grow the company in a few years from just a small-dollar startup, to a million-dollar enterprise. Shah did so well with the business that he was able to let others manage it while he took time off to spend with his family. Shah is considered retired today and lives in Dubai, the UAE’s largest city.